Molecules and Cells

Cited by CrossRef (150)

  1. Mahmoud Nateghi Rostami. CRISPR/Cas9 gene drive technology to control transmission of vector‐borne parasitic infections. Parasite Immunology 2020;42
    https://doi.org/10.1111/pim.12762
  2. Katsuhito Watanabe, Takashi Nakamura, Shoko Onodera, Akiko Saito, Takahiko Shibahara, Toshifumi Azuma. A novel GNAS-mutated human induced pluripotent stem cell model for understanding GNAS-mutated tumors. Tumour Biol. 2020;42:101042832096258
    https://doi.org/10.1177/1010428320962588
  3. Fei Zhang, Guoxu Song, Yong Tian. Anti‐CRISPRs: The natural inhibitors for CRISPR‐Cas systems. Anim Models and Exp Med 2019;2:69
    https://doi.org/10.1002/ame2.12069
  4. Lang Yi, Jinming Li. CRISPR-Cas9 therapeutics in cancer: promising strategies and present challenges. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2016;1866:197
    https://doi.org/10.1016/j.bbcan.2016.09.002
  5. Lindsey A Lonowski, Yoshiki Narimatsu, Anjum Riaz, Catherine E Delay, Zhang Yang, Francesco Niola, Katarzyna Duda, Elke A Ober, Henrik Clausen, Hans H Wandall, Steen H Hansen, Eric P Bennett, Morten Frödin. Genome editing using FACS enrichment of nuclease-expressing cells and indel detection by amplicon analysis. Nat Protoc 2017;12:581
    https://doi.org/10.1038/nprot.2016.165
  6. Jing Wu, Hao Yin. Engineering guide RNA to reduce the off-target effects of CRISPR. Journal of Genetics and Genomics 2019;46:523
    https://doi.org/10.1016/j.jgg.2019.11.003
  7. Shailja Pant, Ritika, Piyali Nag, Amit Ghati, Dipjyoti Chakraborty, Mariana Rocha Maximiano, Octavio Luiz Franco, Amit Kumar Mandal, Arindam Kuila. Employment of the CRISPR/Cas9 system to improve cellulase production in Trichoderma reesei. Biotechnology Advances 2022;60:108022
    https://doi.org/10.1016/j.biotechadv.2022.108022
  8. Muhammad Jawad Akbar Awan, Komal Pervaiz, Awais Rasheed, Imran Amin, Nasir A. Saeed, Kanwarpal S. Dhugga, Shahid Mansoor. Genome edited wheat- current advances for the second green revolution. Biotechnology Advances 2022;60:108006
    https://doi.org/10.1016/j.biotechadv.2022.108006
  9. Patricia Chen, Liting You, You Lu. Applications of CRISPR-Cas9 Technology in Translational Research on Solid-Tumor Cancers. The CRISPR Journal 2018;1:47
    https://doi.org/10.1089/crispr.2017.0001
  10. Máté Varga, Dorottya Ralbovszki, Eszter Balogh, Renáta Hamar, Magdolna Keszthelyi, Kálmán Tory. Zebrafish Models of Rare Hereditary Pediatric Diseases. Diseases 2018;6:43
    https://doi.org/10.3390/diseases6020043
  11. Qianru Sun, Xionghao Liu, Yong Wu, Wenbin Niu, Panpan Long, Jing Liu, Ming Lei, Youjin Hu, Lingqian Wu, Zhuo Li, Desheng Liang. Ectopic expression of factor VIII in MSCs and hepatocytes derived from rDNA targeted hESCs. Clinica Chimica Acta 2019;495:656
    https://doi.org/10.1016/j.cca.2018.08.007
  12. Daesik Kim, Jin-Soo Kim. DIG-seq: a genome-wide CRISPR off-target profiling method using chromatin DNA. Genome Res. 2018;28:1894
    https://doi.org/10.1101/gr.236620.118
  13. Kentaro Ishida, Peter Gee, Akitsu Hotta. Minimizing off-Target Mutagenesis Risks Caused by Programmable Nucleases. IJMS 2015;16:24751
    https://doi.org/10.3390/ijms161024751
  14. Sylvia Merkert, Ulrich Martin. Engineering and Application of Pluripotent Stem Cells. 2015.
    https://doi.org/10.1007/10_2017_25
  15. Jill A Fahrner, Hans T Bjornsson. Mendelian disorders of the epigenetic machinery: postnatal malleability and therapeutic prospects. 2019;28:R254
    https://doi.org/10.1093/hmg/ddz174
  16. Su Bin Moon, Do Yon Kim, Jeong-Heon Ko, Yong-Sam Kim. Recent advances in the CRISPR genome editing tool set. Exp Mol Med 2019;51:1
    https://doi.org/10.1038/s12276-019-0339-7
  17. Jeffrey L. Bessen, Lena K. Afeyan, Vlado Dančík, Luke W. Koblan, David B. Thompson, Chas Leichner, Paul A. Clemons, David R. Liu. High-resolution specificity profiling and off-target prediction for site-specific DNA recombinases. Nat Commun 2019;10
    https://doi.org/10.1038/s41467-019-09987-0
  18. Chidananda Nagamangala Kanchiswamy. DNA-free genome editing methods for targeted crop improvement. Plant Cell Rep 2016;35:1469
    https://doi.org/10.1007/s00299-016-1982-2
  19. Erik J. Quiroz, Amy L. Ryan (Firth). Stem Cell-Based Therapy for Lung Disease. 2016.
    https://doi.org/10.1007/978-3-030-29403-8_9
  20. Suzy Markossian, Frédéric Flamant. CRISPR/Cas9: a breakthrough in generating mouse models for endocrinologists. 2016;57:R81
    https://doi.org/10.1530/JME-15-0305
  21. Georges Blattner, Alessia Cavazza, Adrian J. Thrasher, Giandomenico Turchiano. Gene Editing and Genotoxicity: Targeting the Off-Targets. Front. Genome Ed. 2020;2
    https://doi.org/10.3389/fgeed.2020.613252
  22. Venera S. Kamburova, Elena V. Nikitina, Shukhrat E. Shermatov, Zabardast T. Buriev, Siva P. Kumpatla, Chandrakanth Emani, Ibrokhim Y. Abdurakhmonov. Genome Editing in Plants: An Overview of Tools and Applications. International Journal of Agronomy 2017;2017:1
    https://doi.org/10.1155/2017/7315351
  23. Manjunath N. Swamy, Haoquan Wu, Premlata Shankar. Recent advances in RNAi-based strategies for therapy and prevention of HIV-1/AIDS. Advanced Drug Delivery Reviews 2016;103:174
    https://doi.org/10.1016/j.addr.2016.03.005
  24. Amar M. Singh, Dustin W. Perry, Valeriya V. Adjan Steffey, Kenneth Miller, Daniel W. Allison. Stem Cell Heterogeneity. 2016.
    https://doi.org/10.1007/7651_2016_324
  25. Masaki Endo, Ayako Nishizawa-Yokoi, Seiichi Toki. Rice Genomics, Genetics and Breeding. 2016.
    https://doi.org/10.1007/978-981-10-7461-5_27
  26. Ayman Eid, Magdy M Mahfouz. Genome editing: the road of CRISPR/Cas9 from bench to clinic. Exp Mol Med 2016;48:e265
    https://doi.org/10.1038/emm.2016.111
  27. Ali Golchin, Forough Shams, Farshid Karami. Cell Biology and Translational Medicine, Volume 8. 2016.
    https://doi.org/10.1007/5584_2019_459
  28. Maria José Pino-Barrio, Yari Giménez, Mariela Villanueva, Marcus Hildenbeutel, Rebeca Sánchez-Dominguez, Sandra Rodríguez-Perales, Roser Pujol, Jordi Surrallés, Paula Río, Toni Cathomen, Claudio Mussolino, Juan Antonio Bueren, Susana Navarro. TALEN mediated gene editing in a mouse model of Fanconi anemia. Sci Rep 2020;10
    https://doi.org/10.1038/s41598-020-63971-z
  29. Giulia Bortolussi, Andrés Fernando Muro. Advances in understanding disease mechanisms and potential treatments for Crigler–Najjar syndrome. Expert Opinion on Orphan Drugs 2018;6:425
    https://doi.org/10.1080/21678707.2018.1495558
  30. Diksha Kumari, Bishun Deo Prasad, Padmanabh Dwivedi, Akash Hidangmayum, Sangita Sahni. CRISPR/Cas9 mediated genome editing tools and their possible role in disease resistance mechanism. Mol Biol Rep 2022;49:11587
    https://doi.org/10.1007/s11033-022-07851-x
  31. Joseph Long, Megan D. Hoban, Aaron R. Cooper, Michael L. Kaufman, Caroline Y. Kuo, Beatriz Campo-Fernandez, Dianne Lumaquin, Roger P. Hollis, Xiaoyan Wang, Donald B. Kohn, Zulema Romero. Characterization of Gene Alterations following Editing of the β-Globin Gene Locus in Hematopoietic Stem/Progenitor Cells. Molecular Therapy 2018;26:468
    https://doi.org/10.1016/j.ymthe.2017.11.001
  32. Shengzhou Shan, Qingfeng Li, Tracy Criswell, Anthony Atala, Yuanyuan Zhang. Stem cell therapy combined with controlled release of growth factors for the treatment of sphincter dysfunction. Cell Biosci 2023;13
    https://doi.org/10.1186/s13578-023-01009-3
  33. Maxime Québatte, Christoph Dehio. Systems-level interference strategies to decipher host factors involved in bacterial pathogen interaction: from RNAi to CRISPRi. Current Opinion in Microbiology 2017;39:34
    https://doi.org/10.1016/j.mib.2017.08.002
  34. Taeyoung Koo, Jin-Soo Kim. Therapeutic applications of CRISPR RNA-guided genome editing. Briefings in Functional Genomics 2017;16:38
    https://doi.org/10.1093/bfgp/elw032
  35. Ryan K. Shultzaberger, Rachel E. Abrams, Challise J. Sullivan, Anthony D. Schmitt, Thomas W. J. Thompson, John Dresios, Hodaka Fujii. Agnostic detection of genomic alterations by holistic DNA structural interrogation. PLoS ONE 2018;13:e0208054
    https://doi.org/10.1371/journal.pone.0208054
  36. Han B. Lee, Brynn N. Sundberg, Ashley N. Sigafoos, Karl J. Clark. Genome Engineering with TALE and CRISPR Systems in Neuroscience. Front. Genet. 2016;7
    https://doi.org/10.3389/fgene.2016.00047
  37. Sanaz Naghizadeh, Behzad Mansoori, Ali Mohammadi, Ebrahim Sakhinia , Behzad Baradaran. Gene Silencing Strategies in Cancer Therapy: An Update for Drug Resistance. CMC 2019;26:6282
    https://doi.org/10.2174/0929867325666180403141554
  38. Sandeep Soni, Donald B. Kohn. Chemistry, manufacturing and controls for gene modified hematopoietic stem cells. Cytotherapy 2019;21:358
    https://doi.org/10.1016/j.jcyt.2018.12.001
  39. Koen J. T. Venken, Alejandro Sarrion‐Perdigones, Paul J. Vandeventer, Nicholas S. Abel, Audrey E. Christiansen, Kristi L. Hoffman. Genome engineering: Drosophila melanogaster and beyond. WIREs Developmental Biology 2016;5:233
    https://doi.org/10.1002/wdev.214
  40. Hong-Bo Liu, Ze Yin, Peng Zheng, Yao Xu, Zhen-Yu Wang, Xi Li, Tong-Cun Zhang, Junxian Lim. Using pgRNA–Cas9 system to knockout MKL1 inhibited cell migration and proliferation. Cogent Biology 2018;4:1426255
    https://doi.org/10.1080/23312025.2018.1426255
  41. Robert Sertori, Monique Trengove, Faiza Basheer, Alister C. Ward, Clifford Liongue. Genome editing in zebrafish: a practical overview. Briefings in Functional Genomics 2016;15:322
    https://doi.org/10.1093/bfgp/elv051
  42. Dan Wang, Cuili Niu, Jingxin Han, Dejun Ma, Zhen Xi. Target DNA mutagenesis-based fluorescence assessment of off-target activity of the CRISPR-Cas9 system. RSC Adv. 2019;9:9067
    https://doi.org/10.1039/C8RA10017A
  43. Paul Martin, Michael Morrison, Ilke Turkmendag, Brigitte Nerlich, Aisling McMahon, Stevienna de Saille, Andrew Bartlett. Genome editing: the dynamics of continuity, convergence, and change in the engineering of life. New Genetics and Society 2020;39:219
    https://doi.org/10.1080/14636778.2020.1730166
  44. Julia R. Heckenast, Lawrence S. Wilkinson, Matthew W. Jones. . 2020.
    https://doi.org/10.1016/bs.adgen.2015.09.001
  45. Han Zhang, Nami McCarty. CRISPR-Cas9 technology and its application in haematological disorders. Br J Haematol 2016;175:208
    https://doi.org/10.1111/bjh.14297
  46. Diana Resetca, Anton Neschadim, Jeffrey A. Medin. Engineering Hematopoietic Cells for Cancer Immunotherapy: Strategies to Address Safety and Toxicity Concerns. 2016;39:249
    https://doi.org/10.1097/CJI.0000000000000134
  47. Akiko Saito, Akio Ooki, Takashi Nakamura, Shoko Onodera, Kamichika Hayashi, Daigo Hasegawa, Takahito Okudaira, Katsuhito Watanabe, Hiroshi Kato, Takeshi Onda, Akira Watanabe, Kenjiro Kosaki, Ken Nishimura, Manami Ohtaka, Mahito Nakanishi, Teruo Sakamoto, Akira Yamaguchi, Kenji Sueishi, Toshifumi Azuma. Targeted reversion of induced pluripotent stem cells from patients with human cleidocranial dysplasia improves bone regeneration in a rat calvarial bone defect model. Stem Cell Res Ther 2018;9
    https://doi.org/10.1186/s13287-017-0754-4
  48. Mahdi Barazesh, Shiva Mohammadi, Yadollah Bahrami, Pooneh Mokarram, Mohammad Hossein Morowvat, Massoud Saidijam, Morteza Karimipoor, Soudabeh Kavousipour, Amir Reza Vosoughi, Korosh Khanaki. CRISPR/Cas9 Technology as a Modern Genetic Manipulation Tool for Recapitulating of Neurodegenerative Disorders in Large Animal Models. CGT 2021;21:130
    https://doi.org/10.2174/1566523220666201214115024
  49. Ivan Seah, Debbie Goh, Hwei Wuen Chan, Xinyi Su. Developing Non-Human Primate Models of Inherited Retinal Diseases. Genes 2022;13:344
    https://doi.org/10.3390/genes13020344
  50. Chul-Yong Park, Duk Hyoung Kim, Jeong Sang Son, Jin Jea Sung, Jaehun Lee, Sangsu Bae, Jong-Hoon Kim, Dong-Wook Kim, Jin-Soo Kim. Functional Correction of Large Factor VIII Gene Chromosomal Inversions in Hemophilia A Patient-Derived iPSCs Using CRISPR-Cas9. Cell Stem Cell 2015;17:213
    https://doi.org/10.1016/j.stem.2015.07.001
  51. Yanjiao Han, Zhefan Yuan, Sijin Luo Zhong, Haoxian Xu, Shaoyi Jiang. Minimizing the off-target frequency of the CRISPR/Cas9 system via zwitterionic polymer conjugation and peptide fusion. Chem. Sci. 2023;14:6375
    https://doi.org/10.1039/D2SC07067G
  52. Shaina N. Porter, Rachel M. Levine, Shondra M. Pruett‐Miller. Comprehensive Physiology. 2023.
    https://doi.org/10.1002/cphy.c180022
  53. Stefanie Klaver-Flores, Hidde A. Zittersteijn, Kirsten Canté-Barrett, Arjan Lankester, Rob C. Hoeben, Manuel A. F. V. Gonçalves, Karin Pike-Overzet, Frank J. T. Staal. Genomic Engineering in Human Hematopoietic Stem Cells: Hype or Hope?. Front. Genome Ed. 2021;2
    https://doi.org/10.3389/fgeed.2020.615619
  54. Jaichandran Sivalingam, Dimitar Kenanov, Hao Han, Ajit Johnson Nirmal, Wai Har Ng, Sze Sing Lee, Jeyakumar Masilamani, Toan Thang Phan, Sebastian Maurer-Stroh, Oi Lian Kon. Multidimensional Genome-wide Analyses Show Accurate FVIII Integration by ZFN in Primary Human Cells. Molecular Therapy 2016;24:607
    https://doi.org/10.1038/mt.2015.223
  55. Thomas Malcolm, David A. Mitchell, Niraj Muni. Second Generation Cell and Gene-based Therapies. 2016.
    https://doi.org/10.1016/B978-0-12-812034-7.00008-X
  56. Indra Mani, Takayuki Arazoe, Vijai Singh. Reprogramming the Genome: CRISPR-Cas-based Human Disease Therapy. 2016.
    https://doi.org/10.1016/bs.pmbts.2021.01.011
  57. Tingting Guo, Yongping Xin, Yi Zhang, Xinyi Gu, Jian Kong. A rapid and versatile tool for genomic engineering in Lactococcus lactis. Microb Cell Fact 2019;18
    https://doi.org/10.1186/s12934-019-1075-3
  58. Hyunji Lee, Jin-Soo Kim. Unexpected CRISPR on-target effects. Nat Biotechnol 2018;36:703
    https://doi.org/10.1038/nbt.4207
  59. Dana Carroll, R. Alta Charo. The societal opportunities and challenges of genome editing. Genome Biol 2015;16
    https://doi.org/10.1186/s13059-015-0812-0
  60. Pooja Manchanda, Yadhu Suneja. Biotechnologies of Crop Improvement, Volume 3. 2015.
    https://doi.org/10.1007/978-3-319-94746-4_5
  61. Sikandar Hayat Khan. Genome-Editing Technologies: Concept, Pros, and Cons of Various Genome-Editing Techniques and Bioethical Concerns for Clinical Application. Molecular Therapy - Nucleic Acids 2019;16:326
    https://doi.org/10.1016/j.omtn.2019.02.027
  62. Daniel B. Graham, David E. Root. Resources for the design of CRISPR gene editing experiments. Genome Biol 2015;16
    https://doi.org/10.1186/s13059-015-0823-x
  63. Manjul Dutt, Choaa A. El-Mohtar, Nian Wang. The Citrus Genome. 2015.
    https://doi.org/10.1007/978-3-030-15308-3_14
  64. S. Julia Wu, Yashar S. Niknafs, Stephanie H. Kim, Katherine Oravecz-Wilson, Cynthia Zajac, Tomomi Toubai, Yaping Sun, Jayendra Prasad, Daniel Peltier, Hideaki Fujiwara, Israel Hedig, Nathan D. Mathewson, Rami Khoriaty, David Ginsburg, Pavan Reddy. A Critical Analysis of the Role of SNARE Protein SEC22B in Antigen Cross-Presentation. Cell Reports 2017;19:2645
    https://doi.org/10.1016/j.celrep.2017.06.013
  65. Zhen Yi, Jiamin Ouyang, Wenmin Sun, Xueshan Xiao, Shiqiang Li, Xiaoyun Jia, Panfeng Wang, Qingjiong Zhang. Biallelic mutations in USP45, encoding a deubiquitinating enzyme, are associated with Leber congenital amaurosis. J Med Genet 2019;56:325
    https://doi.org/10.1136/jmedgenet-2018-105709
  66. Andrew Atkins, Cheng-Han Chung, Alexander G. Allen, Will Dampier, Theodore E. Gurrola, Ilker K. Sariyer, Michael R. Nonnemacher, Brian Wigdahl. Off-Target Analysis in Gene Editing and Applications for Clinical Translation of CRISPR/Cas9 in HIV-1 Therapy. Front. Genome Ed. 2021;3
    https://doi.org/10.3389/fgeed.2021.673022
  67. Nikoletta Psatha, Kiriaki Paschoudi, Anastasia Papadopoulou, Evangelia Yannaki. In Vivo Hematopoietic Stem Cell Genome Editing: Perspectives and Limitations. Genes 2022;13:2222
    https://doi.org/10.3390/genes13122222
  68. Shuhan Lu, Ying Zhang, Hao Yin. CRISPR Guide RNA Design. 2022.
    https://doi.org/10.1007/978-1-0716-0687-2_6
  69. Hao Li, Chunyu Sheng, Hongbo Liu, Shan Wang, Jiangyun Zhao, Lang Yang, Leili Jia, Peng Li, Ligui Wang, Jing Xie, Dongping Xu, Yansong Sun, Shaofu Qiu, Hongbin Song. Inhibition of HBV Expression in HBV Transgenic Mice Using AAV-Delivered CRISPR-SaCas9. Front. Immunol. 2018;9
    https://doi.org/10.3389/fimmu.2018.02080
  70. D.R. Ede, N. Farhang, J.D. Stover, R.D. Bowles. Comprehensive Biomaterials II. 2018.
    https://doi.org/10.1016/B978-0-12-803581-8.09290-0
  71. George Nicholas Llewellyn, Colin M. Exline, Nathalia Holt, Paula M. Cannon. Genome Editing. 2018.
    https://doi.org/10.1007/978-1-4939-3509-3_10
  72. Hongen Wei, Min Wang, Na Lv, Hua Yang, Min Zhao, Bo Huang, Rongshan Li. Increased repetitive self-grooming occurs in Pax2 mutant mice generated using CRISPR/Cas9. Behavioural Brain Research 2020;393:112803
    https://doi.org/10.1016/j.bbr.2020.112803
  73. Alison Louise Van Eenennaam. Genetic modification of food animals. Current Opinion in Biotechnology 2017;44:27
    https://doi.org/10.1016/j.copbio.2016.10.007
  74. Sen Yang, Yang Wang, Chaobao Wei, Qingtao Liu, Xuerong Jin, Guocheng Du, Jian Chen, Zhen Kang. A new sRNA‐mediated posttranscriptional regulation system for Bacillus subtilis. Biotech & Bioengineering 2018;115:2986
    https://doi.org/10.1002/bit.26833
  75. Bing Shui, Liz Hernandez Matias, Yi Guo, Ying Peng. The Rise of CRISPR/Cas for Genome Editing in Stem Cells. Stem Cells International 2016;2016:1
    https://doi.org/10.1155/2016/8140168
  76. Ming Xu, Hongzhi Xu, Jian Chen, Chunjui Chen, Feng Xu, Zhiyong Qin. Generation of conditional Acvrl1 knockout mice by CRISPR/Cas9-mediated gene targeting. Molecular and Cellular Probes 2018;37:32
    https://doi.org/10.1016/j.mcp.2017.11.003
  77. Luan Wen, Changzhi Zhao, Jun Song, Linyuan Ma, Jinxue Ruan, Xiaofeng Xia, Y. Eugene Chen, Jifeng Zhang, Peter X. Ma, Jie Xu. CRISPR/Cas9-Mediated TERT Disruption in Cancer Cells. IJMS 2020;21:653
    https://doi.org/10.3390/ijms21020653
  78. Srinivasan Chandrasegaran, Dana Carroll. Origins of Programmable Nucleases for Genome Engineering. Journal of Molecular Biology 2016;428:963
    https://doi.org/10.1016/j.jmb.2015.10.014
  79. Jinxue Ruan, Hiroyuki Hirai, Dongshan Yang, Linyuan Ma, Xia Hou, Hong Jiang, Hongguang Wei, Carthic Rajagopalan, Hongmei Mou, Guoshun Wang, Jifeng Zhang, Kui Li, Yuqing E. Chen, Fei Sun, Jie Xu. Efficient Gene Editing at Major CFTR Mutation Loci. Molecular Therapy - Nucleic Acids 2019;16:73
    https://doi.org/10.1016/j.omtn.2019.02.006
  80. Van Trang Le, Me-Sun Kim, Yu-Jin Jung, Kwon-Kyoo Kang, Yong-Gu Cho. Research Trends and Challenges of Using CRISPR/Cas9 for Improving Rice Productivity. Agronomy 2022;12:164
    https://doi.org/10.3390/agronomy12010164
  81. Becky Xu Hua Fu, Justin D. Smith, Ryan T. Fuchs, Megumu Mabuchi, Jennifer Curcuru, G. Brett Robb, Andrew Z. Fire. Target-dependent nickase activities of the CRISPR–Cas nucleases Cpf1 and Cas9. Nat Microbiol 2019;4:888
    https://doi.org/10.1038/s41564-019-0382-0
  82. Do Yon Kim, Su Bin Moon, Yong-Sam Kim. Improving CRISPR Technology to Sustain Animal Welfare: Response to Bailey. Trends in Biotechnology 2019;37:922
    https://doi.org/10.1016/j.tibtech.2019.05.010
  83. Weizheng Liang, Junli He, Chenyu Mao, Chengwei Yu, Qingxue Meng, Jun Xue, Xueliang Wu, Shanliang Li, Yukai Wang, Hongyang Yi. Gene editing monkeys: Retrospect and outlook. Front. Cell Dev. Biol. 2022;10
    https://doi.org/10.3389/fcell.2022.913996
  84. Radu Gugustea, Zhengping Jia. Genetic manipulations of AMPA glutamate receptors in hippocampal synaptic plasticity. Neuropharmacology 2021;194:108630
    https://doi.org/10.1016/j.neuropharm.2021.108630
  85. Ran Peng, Ye Wang, Wan-wan Feng, Xin-jing Yue, Jiang-he Chen, Xiao-zhuang Hu, Zhi-feng Li, Duo-hong Sheng, You-ming Zhang, Yue-zhong Li. CRISPR/dCas9-mediated transcriptional improvement of the biosynthetic gene cluster for the epothilone production in Myxococcus xanthus. Microb Cell Fact 2018;17
    https://doi.org/10.1186/s12934-018-0867-1
  86. Neftali Vazquez, Lilia Sanchez, Rebecca Marks, Eduardo Martinez, Victor Fanniel, Alma Lopez, Andrea Salinas, Itzel Flores, Jesse Hirschmann, Robert Gilkerson, Erin Schuenzel, Robert Dearth, Reginald Halaby, Wendy Innis-Whitehouse, Megan Keniry. A protocol for custom CRISPR Cas9 donor vector construction to truncate genes in mammalian cells using pcDNA3 backbone. BMC Molecular Biol 2018;19
    https://doi.org/10.1186/s12867-018-0105-8
  87. Javaria Tabassum, Shakeel Ahmad, Babar Hussain, Amos Musyoki Mawia, Aqib Zeb, Luo Ju. Applications and Potential of Genome-Editing Systems in Rice Improvement: Current and Future Perspectives. Agronomy 2021;11:1359
    https://doi.org/10.3390/agronomy11071359
  88. Kun Jia, Yan-ru Cui, Shisheng Huang, Peihong Yu, Zhengxing Lian, Peixiang Ma, Jia Liu. Phage peptides mediate precision base editing with focused targeting window. Nat Commun 2022;13
    https://doi.org/10.1038/s41467-022-29365-7
  89. Liudmila A. Abrosimova, Anzhela Yu. Migur, Elena A. Kubareva, Timofei S. Zatsepin, Aleksandra V. Gavshina, Alfiya K. Yunusova, Tatiana A. Perevyazova, Alfred Pingoud, Tatiana S. Oretskaya, Shuang-yong Xu. A study on endonuclease BspD6I and its stimulus-responsive switching by modified oligonucleotides. PLoS ONE 2018;13:e0207302
    https://doi.org/10.1371/journal.pone.0207302
  90. Tariq Shah, Tayyaba Andleeb, Sadia Lateef, Mehmood Ali Noor. Genome editing in plants: Advancing crop transformation and overview of tools. Plant Physiology and Biochemistry 2018;131:12
    https://doi.org/10.1016/j.plaphy.2018.05.009
  91. Amar Singh. Gene Editing in Human Pluripotent Stem Cells: Choosing the Correct Path. JSCRB 2015;1:1
    https://doi.org/10.15436/2741-0598.15.004
  92. Dongqi Ni, Jinhui Lin, Nuozi Zhang, Shilin Li, Yueguang Xue, Ziyao Wang, Qianglin Liu, Kai Liu, Hongjie Zhang, Yuliang Zhao, Chunying Chen, Ying Liu. Combinational application of metal–organic frameworks‐based nanozyme and nucleic acid delivery in cancer therapy. WIREs Nanomed Nanobiotechnol 2022;14
    https://doi.org/10.1002/wnan.1773
  93. Minyoung Lee, Hyongbum Kim. Therapeutic application of the CRISPR system: current issues and new prospects. Hum Genet 2019;138:563
    https://doi.org/10.1007/s00439-019-02028-2
  94. Maximilian Müller, Ciaran M Lee, Giedrius Gasiunas, Timothy H Davis, Thomas J Cradick, Virginijus Siksnys, Gang Bao, Toni Cathomen, Claudio Mussolino. Streptococcus thermophilus CRISPR-Cas9 Systems Enable Specific Editing of the Human Genome. Molecular Therapy 2016;24:636
    https://doi.org/10.1038/mt.2015.218
  95. Yaxin Wang, Naeem Zafar, Qurban Ali, Hakim Manghwar, Guanying Wang, Lu Yu, Xiao Ding, Fang Ding, Ni Hong, Guoping Wang, Shuangxia Jin. CRISPR/Cas Genome Editing Technologies for Plant Improvement against Biotic and Abiotic Stresses: Advances, Limitations, and Future Perspectives. Cells 2022;11:3928
    https://doi.org/10.3390/cells11233928
  96. Christine L. Xu, Merry Zhechao Ruan, Sara D. Ragi, Stephen H. Tsang. Retinitis Pigmentosa. 2022.
    https://doi.org/10.1007/978-1-0716-2651-1_26
  97. Mickael Malnoy, Roberto Viola, Min-Hee Jung, Ok-Jae Koo, Seokjoong Kim, Jin-Soo Kim, Riccardo Velasco, Chidananda Nagamangala Kanchiswamy. DNA-Free Genetically Edited Grapevine and Apple Protoplast Using CRISPR/Cas9 Ribonucleoproteins. Front. Plant Sci. 2016;7
    https://doi.org/10.3389/fpls.2016.01904
  98. Xiaojie Xu, Tao Wan, Huhu Xin, Da Li, Hongming Pan, Jun Wu, Yuan Ping. Delivery of CRISPR/Cas9 for therapeutic genome editing. The Journal of Gene Medicine 2019;21
    https://doi.org/10.1002/jgm.3107
  99. Jinjing Li, Shunyan Hong, Wanjin Chen, Erwei Zuo, Hui Yang. Advances in detecting and reducing off-target effects generated by CRISPR-mediated genome editing. Journal of Genetics and Genomics 2019;46:513
    https://doi.org/10.1016/j.jgg.2019.11.002
  100. Junwon Lee, Jae‐Hee Chung, Ho Min Kim, Dong‐Wook Kim, Hyongbum Kim. Designed nucleases for targeted genome editing. Plant Biotechnology Journal 2016;14:448
    https://doi.org/10.1111/pbi.12465
  101. Shakeel Ahmad, Xiangjin Wei, Zhonghua Sheng, Peisong Hu, Shaoqing Tang. CRISPR/Cas9 for development of disease resistance in plants: recent progress, limitations and future prospects. 2020;19:26
    https://doi.org/10.1093/bfgp/elz041
  102. Jinyu Zhang, Yi Zhang, Sushant Khanal, Dechao Cao, Juan Zhao, Xindi Dang, Lam Ngoc Thao Nguyen, Madison Schank, Xiao Y. Wu, Yong Jiang, Shunbin Ning, Ling Wang, Mohamed El Gazzar, Jonathan P. Moorman, Haitao Guo, Zhi Q. Yao. Synthetic gRNA/Cas9 ribonucleoprotein targeting HBV DNA inhibits viral replication. Journal of Medical Virology 2023;95
    https://doi.org/10.1002/jmv.28952
  103. Marta Martinez-Lage, Raúl Torres-Ruiz, Sandra Rodriguez-Perales. CRISPR in Animals and Animal Models. 2023.
    https://doi.org/10.1016/bs.pmbts.2017.09.002
  104. Kellie A Schaefer, Wen-Hsuan Wu, Diana F Colgan, Stephen H Tsang, Alexander G Bassuk, Vinit B Mahajan. Unexpected mutations after CRISPR–Cas9 editing in vivo. Nat Methods 2017;14:547
    https://doi.org/10.1038/nmeth.4293
  105. Prashant Kumar, Yashpal Singh Malik, Balasubramanian Ganesh, Somnath Rahangdale, Sharad Saurabh, Senthilkumar Natesan, Ashish Srivastava, Khan Sharun, Mohd. Iqbal Yatoo, Ruchi Tiwari, Raj Kumar Singh, Kuldeep Dhama. CRISPR-Cas System: An Approach With Potentials for COVID-19 Diagnosis and Therapeutics. Front. Cell. Infect. Microbiol. 2020;10
    https://doi.org/10.3389/fcimb.2020.576875
  106. Jaesuk Lee, Delger Bayarsaikhan, Govigerel Bayarsaikhan, Jin-Soo Kim, Elizabeth Schwarzbach, Bonghee Lee. Recent advances in genome editing of stem cells for drug discovery and therapeutic application. Pharmacology & Therapeutics 2020;209:107501
    https://doi.org/10.1016/j.pharmthera.2020.107501
  107. Chidananda Nagamangala Kanchiswamy, Massimo Maffei, Mickael Malnoy, Riccardo Velasco, Jin-Soo Kim. Fine-Tuning Next-Generation Genome Editing Tools. Trends in Biotechnology 2016;34:562
    https://doi.org/10.1016/j.tibtech.2016.03.007
  108. Hong Jo Lee, Hyung Chul Lee, Jae Yong Han. Germline Modification and Engineering in Avian Species. 2015;38:743
    https://doi.org/10.14348/molcells.2015.0225
  109. Cheng Ye, Benjamin E. Low, Michael V. Wiles, Todd M. Brusko, David V. Serreze, John P. Driver. CD70 Inversely Regulates Regulatory T Cells and Invariant NKT Cells and Modulates Type 1 Diabetes in NOD Mice. 2020;205:1763
    https://doi.org/10.4049/jimmunol.2000148
  110. Mujeeb ur Rahman, Muhammad Bilal, Junaid Ali Shah, Ajeet Kaushik, Pierre-Louis Teissedre, Małgorzata Kujawska. CRISPR-Cas9-Based Technology and Its Relevance to Gene Editing in Parkinson’s Disease. Pharmaceutics 2022;14:1252
    https://doi.org/10.3390/pharmaceutics14061252
  111. Sushant Khanal, Dechao Cao, Jinyu Zhang, Yi Zhang, Madison Schank, Xindi Dang, Lam Ngoc Thao Nguyen, Xiao Y. Wu, Yong Jiang, Shunbin Ning, Juan Zhao, Ling Wang, Mohamed El Gazzar, Jonathan P. Moorman, Zhi Q. Yao. Synthetic gRNA/Cas9 Ribonucleoprotein Inhibits HIV Reactivation and Replication. Viruses 2022;14:1902
    https://doi.org/10.3390/v14091902
  112. Muntazir Mushtaq, Aafreen Sakina, Shabir Hussain Wani, Asif B. Shikari, Prateek Tripathi, Abbu Zaid, Aravind Galla, Mostafa Abdelrahman, Manmohan Sharma, Anil Kumar Singh, Romesh Kumar Salgotra. Harnessing Genome Editing Techniques to Engineer Disease Resistance in Plants. Front. Plant Sci. 2019;10
    https://doi.org/10.3389/fpls.2019.00550
  113. Tuhin Guha, David Edgell. Applications of Alternative Nucleases in the Age of CRISPR/Cas9. IJMS 2017;18:2565
    https://doi.org/10.3390/ijms18122565
  114. Zhenwu Zhang, Xinyu Bao, Chao-Po Lin. Progress and Prospects of Gene Editing in Pluripotent Stem Cells. Biomedicines 2023;11:2168
    https://doi.org/10.3390/biomedicines11082168
  115. Juan I. Castrillo, Simone Lista, Harald Hampel, Craig W. Ritchie. Biomarkers for Alzheimer’s Disease Drug Development. 2023.
    https://doi.org/10.1007/978-1-4939-7704-8_3
  116. Paul Harmatz, Carlos E. Prada, Barbara K. Burton, Heather Lau, Craig M. Kessler, Liching Cao, Marina Falaleeva, Andres G. Villegas, Jennifer Zeitler, Kathleen Meyer, Weston Miller, Cheryl Wong Po Foo, Sagar Vaidya, Wendy Swenson, Lisa H. Shiue, Didier Rouy, Joseph Muenzer. First-in-human in vivo genome editing via AAV-zinc-finger nucleases for mucopolysaccharidosis I/II and hemophilia B. Molecular Therapy 2022;30:3587
    https://doi.org/10.1016/j.ymthe.2022.10.010
  117. Jin-Soo Kim. Genome editing comes of age. Nat Protoc 2016;11:1573
    https://doi.org/10.1038/nprot.2016.104
  118. Daniel Brown, Leigh Samsa, Li Qian, Jiandong Liu. Advances in the Study of Heart Development and Disease Using Zebrafish. JCDD 2016;3:13
    https://doi.org/10.3390/jcdd3020013
  119. Jie Luo, Piyush Padhi, Huajun Jin, Vellareddy Anantharam, Gary Zenitsky, Qian Wang, Auriel A. Willette, Arthi Kanthasamy, Anumantha G. Kanthasamy. Utilization of the CRISPR-Cas9 Gene Editing System to Dissect Neuroinflammatory and Neuropharmacological Mechanisms in Parkinson’s Disease. J Neuroimmune Pharmacol 2019;14:595
    https://doi.org/10.1007/s11481-019-09844-3
  120. Zeenat Mirza, Sajjad Karim. Advancements in CRISPR/Cas9 technology—Focusing on cancer therapeutics and beyond. Seminars in Cell & Developmental Biology 2019;96:13
    https://doi.org/10.1016/j.semcdb.2019.05.026
  121. Dana Carroll. A Perspective on the State of Genome Editing. Molecular Therapy 2016;24:412
    https://doi.org/10.1038/mt.2016.28
  122. Hong-Xia Zhang, Ying Zhang, Hao Yin. Genome Editing with mRNA Encoding ZFN, TALEN, and Cas9. Molecular Therapy 2019;27:735
    https://doi.org/10.1016/j.ymthe.2019.01.014
  123. Daesik Kim, Beum-Chang Kang, Jin-Soo Kim. Identifying genome-wide off-target sites of CRISPR RNA–guided nucleases and deaminases with Digenome-seq. Nat Protoc 2021;16:1170
    https://doi.org/10.1038/s41596-020-00453-6
  124. Lisa Lombardi, Siobhán A. Turner, Fang Zhao, Geraldine Butler. Gene editing in clinical isolates of Candida parapsilosis using CRISPR/Cas9. Sci Rep 2017;7
    https://doi.org/10.1038/s41598-017-08500-1
  125. Hui-Ying Xue, Li-Juan Ji, Ai-Mei Gao, Ping Liu, Jing-Dong He, Xiao-Jie Lu. CRISPR-Cas9 for medical genetic screens: applications and future perspectives. J Med Genet 2016;53:91
    https://doi.org/10.1136/jmedgenet-2015-103409
  126. S. V. Gerasimova, E. K. Khlestkina, A. V. Kochetov, V. K. Shumny. Genome editing system CRISPR/CAS9 and peculiarities of its application in monocots. Russ J Plant Physiol 2017;64:141
    https://doi.org/10.1134/S1021443717010071
  127. Winnie W.Y. Lau, Cedric Ghevaert. Advances in generating HLA-Universal platelets for transfusion medicine. Journal of Immunology and Regenerative Medicine 2021;14:100053
    https://doi.org/10.1016/j.regen.2021.100053
  128. Zaid Saad Madhi, Mohammed Ali Shallan, Abdulhusein Mizhir Almaamuri, Ammar Abbas Alhussainy, Sadiq Salam S. AL- Salih, Abdulla K. Raheem, Hameed Jassem Alwan, Abduladheem Turki Jalil. Lipids and lipid derivatives for delivery of the CRISPR/Cas9 system. Journal of Drug Delivery Science and Technology 2022;78:103948
    https://doi.org/10.1016/j.jddst.2022.103948
  129. Cia-Hin Lau, Yousin Suh. In vivo genome editing in animals using AAV-CRISPR system: applications to translational research of human disease. F1000Res 2017;6:2153
    https://doi.org/10.12688/f1000research.11243.1
  130. Yan-ru Cui, Shao-jie Wang, Jun Chen, Jie Li, Wenzhang Chen, Shuyue Wang, Bing Meng, Wei Zhu, Zhuhong Zhang, Bei Yang, Biao Jiang, Guang Yang, Peixiang Ma, Jia Liu. Allosteric inhibition of CRISPR-Cas9 by bacteriophage-derived peptides. Genome Biol 2020;21
    https://doi.org/10.1186/s13059-020-01956-x
  131. Hongmei Lisa Li, Peter Gee, Kentaro Ishida, Akitsu Hotta. Efficient genomic correction methods in human iPS cells using CRISPR–Cas9 system. Methods 2016;101:27
    https://doi.org/10.1016/j.ymeth.2015.10.015
  132. Henriette O’Geen, Abigail S Yu, David J Segal. How specific is CRISPR/Cas9 really?. Current Opinion in Chemical Biology 2015;29:72
    https://doi.org/10.1016/j.cbpa.2015.10.001
  133. E. Sacide Çağlayan. Generation of improved human cerebral organoids from single copyDYRK1Aknockout induced pluripotent stem cells in trisomy 21: hypothetical solutions for neurodevelopmental models and therapeutic alternatives in down syndrome. Cell Biol Int 2016;40:1256
    https://doi.org/10.1002/cbin.10694
  134. Zachary J. Waldrip, Piroon Jenjaroenpun, Oktawia DeYoung, Intawat Nookaew, Sean D. Taverna, Kevin D. Raney, Alan J. Tackett. Genome-wide Cas9 binding specificity in Saccharomyces cerevisiae. 2020;8:e9442
    https://doi.org/10.7717/peerj.9442
  135. Galaxy Y. Cho, Kellie A. Schaefer, Alexander G. Bassuk, Stephen H. Tsang, Vinit B. Mahajan. CRISPR GENOME SURGERY IN THE RETINA IN LIGHT OF OFF-TARGETING. 2018;38:1443
    https://doi.org/10.1097/IAE.0000000000002197
  136. Zulqurnain Khan, Tahmina Sattar, Maria Siddique, Zulfiqar Ali, Asif Ali Khan, Syed Ovais Aftab, Muhammad Zubair Ghouri, Qaisar Sultan, Nauman Gulzar, Farooq Ahmad. The CRISPR/Cas Tool Kit for Genome Editing. 2018.
    https://doi.org/10.1007/978-981-16-6305-5_5
  137. Josh Tycko, Vic E. Myer, Patrick D. Hsu. Methods for Optimizing CRISPR-Cas9 Genome Editing Specificity. Molecular Cell 2016;63:355
    https://doi.org/10.1016/j.molcel.2016.07.004
  138. A. K. Beylin, N. G. Gurskaya, E. A. Vorotelyak. Methods of Gene Therapy for Treatment of Inherited Epidermolysis Bullosa. Moscow Univ. Biol.Sci. Bull. 2018;73:191
    https://doi.org/10.3103/S0096392518040016
  139. Nan Wu, Bowen Liu, Huakang Du, Sen Zhao, Yaqi Li, Xi Cheng, Shengru Wang, Jiachen Lin, Junde Zhou, Guixing Qiu, Zhihong Wu, Jianguo Zhang. The Progress of CRISPR/Cas9-Mediated Gene Editing in Generating Mouse/Zebrafish Models of Human Skeletal Diseases. Computational and Structural Biotechnology Journal 2019;17:954
    https://doi.org/10.1016/j.csbj.2019.06.006
  140. Bilal Ahmad Lone, Shibendra Kumar Lal Karna, Faiz Ahmad, Nerina Shahi, Yuba Raj Pokharel. CRISPR/Cas9 System: A Bacterial Tailor for Genomic Engineering. Genetics Research International 2018;2018:1
    https://doi.org/10.1155/2018/3797214
  141. Jianwu Chen, Karly G. Aimanova, Sarjeet S. Gill, Mariangela Bonizzoni. Aedes cadherin receptor that mediates Bacillus thuringiensis Cry11A toxicity is essential for mosquito development. PLoS Negl Trop Dis 2020;14:e0007948
    https://doi.org/10.1371/journal.pntd.0007948
  142. Chul-Yong Park, Jin Jea Sung, Sang-Hwi Choi, Dongjin R Lee, In-Hyun Park, Dong-Wook Kim. Modeling and correction of structural variations in patient-derived iPSCs using CRISPR/Cas9. Nat Protoc 2016;11:2154
    https://doi.org/10.1038/nprot.2016.129
  143. Xiaoqiang Huang, Dongshan Yang, Jifeng Zhang, Jie Xu, Y. Eugene Chen. Recent Advances in Improving Gene-Editing Specificity through CRISPR–Cas9 Nuclease Engineering. Cells 2022;11:2186
    https://doi.org/10.3390/cells11142186
  144. Ala Moshiri, Amirfarbod Yazdanyar. Vitreoretinal Disorders. 2022.
    https://doi.org/10.1007/978-981-10-8545-1_5
  145. Hui Xing, Ling-hua Meng. CRISPR-cas9: a powerful tool towards precision medicine in cancer treatment. Acta Pharmacol Sin 2020;41:583
    https://doi.org/10.1038/s41401-019-0322-9
  146. Dennis Huang, Matthew Miller, Bhaargavi Ashok, Samagra Jain, Nicholas A. Peppas. CRISPR/Cas systems to overcome challenges in developing the next generation of T cells for cancer therapy. Advanced Drug Delivery Reviews 2020;158:17
    https://doi.org/10.1016/j.addr.2020.07.015
  147. Cheng-Han Chung, Alexander G. Allen, Neil T. Sullivan, Andrew Atkins, Michael R. Nonnemacher, Brian Wigdahl, Will Dampier. Computational Analysis Concerning the Impact of DNA Accessibility on CRISPR-Cas9 Cleavage Efficiency. Molecular Therapy 2020;28:19
    https://doi.org/10.1016/j.ymthe.2019.10.008
  148. Zulqurnain Khan, Tahira Saboor, Muhammad Ashfaq, Abubakar Saddique, Plosha Khanum. CRISPR Crops. 2020.
    https://doi.org/10.1007/978-981-15-7142-8_5
  149. Naglaa A Abdallah, Channapatna S Prakash, Alan G McHughen. Genome editing for crop improvement: Challenges and opportunities. GM Crops & Food 2015;6:183
    https://doi.org/10.1080/21645698.2015.1129937
  150. Abidemi Adegbola, Luke A. Bury, Chen Fu, Meixiang Zhang, Anthony Wynshaw-Boris. Concise Review: Induced Pluripotent Stem Cell Models for Neuropsychiatric Diseases. 2017;6:2062
    https://doi.org/10.1002/sctm.17-0150